Literature DB >> 8631795

Slow binding inhibition of phospho-N-acetylmuramyl-pentapeptide-translocase (Escherichia coli) by mureidomycin A.

P E Brandish1, M K Burnham, J T Lonsdale, R Southgate, M Inukai, T D Bugg.   

Abstract

Enzymes of the membrane cycle of reactions in bacterial peptidoglycan biosynthesis remain as unexploited potential targets for antibacterial agents. The first of these enzymes, phospho-N-acetylmuramyl-pentapeptide-translocase (EC 2.7.8.13), has been overexpresed in Escherichia coli and solubilized from particulate fractions. The work of W.A. Weppner and F.C. Neuhaus ((1977) J. Biol. Chem. 252, 2296-303) has been extended to establish a usable routine fluorescence-based continuous assay for solubilized preparations. This assay has been used in the characterization of the natural product, mureidomycin A as a potent slow binding inhibitor of the enzyme with Ki and Ki* of 36 nM and 2 nM, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631795     DOI: 10.1074/jbc.271.13.7609

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis.

Authors:  T G Bernhardt; W D Roof; R Young
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

2.  Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus.

Authors:  H Maki; K Miura; Y Yamano
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Fluorescence detection-based functional assay for high-throughput screening for MraY.

Authors:  Thérèse Stachyra; Christophe Dini; Paul Ferrari; Ahmed Bouhss; Jean van Heijenoort; Dominique Mengin-Lecreulx; Didier Blanot; Jacques Biton; Dominique Le Beller
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

4.  Scintillation proximity assay for inhibitors of Escherichia coli MurG and, optionally, MraY.

Authors:  Sudha Ravishankar; Vidya Prasanna Kumar; B Chandrakala; Ramesh K Jha; Suresh M Solapure; Sunita M de Sousa
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Purification and functional characterization of phiX174 lysis protein E.

Authors:  Yi Zheng; Douglas K Struck; Ry Young
Journal:  Biochemistry       Date:  2009-06-09       Impact factor: 3.162

6.  mraY is an essential gene for cell growth in Escherichia coli.

Authors:  D S Boyle; W D Donachie
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

Review 7.  Uridine natural products: Challenging targets and inspiration for novel small molecule inhibitors.

Authors:  Christine A Arbour; Barbara Imperiali
Journal:  Bioorg Med Chem       Date:  2020-07-30       Impact factor: 3.641

8.  Insights into the Target Interaction of Naturally Occurring Muraymycin Nucleoside Antibiotics.

Authors:  Stefan Koppermann; Zheng Cui; Patrick D Fischer; Xiachang Wang; Jannine Ludwig; Jon S Thorson; Steven G Van Lanen; Christian Ducho
Journal:  ChemMedChem       Date:  2018-03-23       Impact factor: 3.466

9.  Antibacterial Muraymycins from Mutant Strains of Streptomyces sp. NRRL 30471.

Authors:  Zheng Cui; Xiachang Wang; Stefan Koppermann; Jon S Thorson; Christian Ducho; Steven G Van Lanen
Journal:  J Nat Prod       Date:  2018-03-19       Impact factor: 4.050

10.  Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I.

Authors:  Shajila Siricilla; Katsuhiko Mitachi; Karolina Skorupinska-Tudek; Ewa Swiezewska; Michio Kurosu
Journal:  Anal Biochem       Date:  2014-06-02       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.